Computational prediction and experimental validation associating FABP-1 and pancreatic adenocarcinoma with diabetes

Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus

(2010) Armin Kolb et al.   CANCER BIOLOGY & THERAPY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Disease signatures are robust across tissues and experiments

(2009) Joel T Dudley et al.   Molecular Systems Biology

Polymorphism -23HPhI in the promoter of insulin gene and pancreatic cancer: A pilot study

(2009) T. Krechler et al.   NEOPLASMA

A Compendium of Potential Biomarkers of Pancreatic Cancer

(2009) H. C. Harsha et al.   PLOS MEDICINE

New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer

(2008) Rahul Pannala et al.   LANCET ONCOLOGY

Liver fatty acid binding protein gene ablation enhances age-dependent weight gain in male mice

(2008) Gregory G. Martin et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets

(2008) Masato Furuhashi et al.   NATURE REVIEWS DRUG DISCOVERY

Diet-induced obesity and hepatic steatosis in L-Fabp−/− mice is abrogated with SF, but not PUFA, feeding and attenuated after cholesterol supplementation

(2007) Elizabeth P. Newberry et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery

(2007) D. Portilla et al.   KIDNEY INTERNATIONAL